x

Rechercher un essai clinique

* (*) Champ obligatoire

154 Résultat(s)

Trier par

Essai en cours de recrutement = Essai en cours de recrutement; Essai en cours = Essai en cours; Financé par un membre IRDiRC =

Essai(s) clinique(s) national(aux)

ALLEMAGNE

Baden-Württemberg
FREIBURG

ALLEMAGNE

Baden-Württemberg
FREIBURG

ALLEMAGNE

Baden-Württemberg
FREIBURG

Essai en coursFOR-DMD: Double-blind randomized phase III trial to find optimum steroid regimen for Duchenne Muscular Dystrophy - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

ALLEMAGNE

Baden-Württemberg
FREIBURG

Essai en coursFinancé par un membre IRDiRCAn Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy (Phase III) - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

ALLEMAGNE

Baden-Württemberg
FREIBURG

ALLEMAGNE

Baden-Württemberg
FREIBURG

Financé par un membre IRDiRCA Phase 3 Efficacy and Safety Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy - DE - Completed
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

ALLEMAGNE

Baden-Württemberg
FREIBURG

Essai en cours de recrutementEssai en coursFinancé par un membre IRDiRCA Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

ALLEMAGNE

Baden-Württemberg
FREIBURG

Essai en cours de recrutementEssai en coursAn open-label safety, tolerability and pharmacokinetics study of Eteplirsen in young patients with Duchenne dystrophy amenable to exon 51 skipping - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

ALLEMAGNE

Nordrhein-Westfalen
ESSEN

CANADA

Ontario
LONDON

ESPAGNE

Cataluña
ESPLUGUES DE LLOBREGAT

ESPAGNE

Comunidad Valenciana
VALENCIA

ESPAGNE

Comunidad Valenciana
VALENCIA

ETATS-UNIS

Florida
GAINESVILLE

ETATS-UNIS

New York
ROCHESTER

FRANCE

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCE

ILE-DE-FRANCE
PARIS

ITALIE

CAMPANIA
NAPOLI

Essai en cours(FOR-DMD): Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
AOU Seconda Università degli Studi di Napoli - Centro storico
Servizio di Cardiomiologia e Genetica Medica

ITALIE

EMILIA ROMAGNA
FERRARA

ITALIE

LAZIO
ROMA

Financé par un membre IRDiRCAn Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy (Phase III) - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
Unità di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare

ITALIE

LAZIO
ROMA

Essai en cours de recrutementEssai en coursOpen Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
Unità di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare

ITALIE

LOMBARDIA
MILANO

ITALIE

VENETO
PADOVA

Essai en cours(FOR-DMD): Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Azienda Ospedaliera Universitaria di Padova - Campus Biomedico Pietro d'Abano
Neuromuscular Laboratory

ROYAUME-UNI

Cambridgeshire
CAMBRIDGE

ROYAUME-UNI

Greater London
LONDON

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en cours de recrutementEssai en coursFinancé par un membre IRDiRCA Phase III Efficacy and Safety Study of Ataluren (PTC124) in Patients with Nonsense Mutation Dystrophinopathy - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en coursAn open-label extension study of the long-term safety, tolerability and efficacy of GSK2402968 in subjects with Duchenne Muscular Dystrophy (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

FOR-DMD: Duchenne muscular dystrophy: doubleblind randomized trial to find optimum steroid regimen (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en coursAn Open-Label Study for Previously Treated Ataluren (PTC124®) Patients with Nonsense Mutation Dystrophinopathy (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

BELGIQUE

VLAAMS BRABANT
LEUVEN

BELGIQUE

VLAAMS BRABANT
LEUVEN

ITALIE

LAZIO
ROMA

A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
Unità di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en coursPTC124-GD-007-DMD: A Phase 2b Efficacy and Safety Study of PTC124 in Subjects with Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SUEDE

Stockholms läns landsting
STOCKHOLM

FRANCE

ILE-DE-FRANCE
GARCHES

Essai en coursLong-Term Effect of LIAM (Lung Insufflation Assist Maneuver) on Respiratory Performance in Non-invasive Ventilated Patients Suffering From Neuromuscular Disease
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Centre d'Investigation Clinique et Technologique 805 - CIC-IT de Garches

FRANCE

ILE-DE-FRANCE
GARCHES

Essai en coursProtocole de Validation Clinique du Logiciel d'Interface Cerveau-Ordinateur RoBIK Pour la Communication Des Patients Atteints de Maladie Neuromusculaires (MNM)
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Centre d'Investigation Clinique et Technologique 805 - CIC-IT de Garches

FRANCE

ILE-DE-FRANCE
GARCHES

Essai en coursEstablishment of a Non-invasive and Indirect Measure of Volitional Pimax (PI MAX STIM)
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de Physiologie-Explorations Fonctionnelles

Essai(s) clinique(s) multinational(aux)

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en coursFinancé par un membre IRDiRCSCOPE-DMD: Consortium for Products across Europe in Duchenne Muscular Dystrophy
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine